Literature DB >> 1094830

Microangiopathic hemolytic anemia in renal allotransplantation. Repart of a successfully treated case and review of the literature.

R L Magalhaes, W E Braun, R A Straffon, G C Hoffman, J R Shainoff, G Osborne, S D Deodhar.   

Abstract

The development of microangiopathic hemolytic anemia after renal transplantation in a 17 year old white boy is reported, and the literature is reviewed. In this patient microangiopathic hemolytic anemia developed 6 weeks after renal transplantation during a second episode of rejection. Light, fluorescence and electron microscopy demonstrated the renal vascular lesion associated with this syndrome. In contrast to the other four previously reported cases of microangiopathic hemolytic anemia associated with renal allotransplantation, this patient had complete resolution of the microangiopathic hemolytic anemia with heparin therapy and improved allograft function, presumably with diminution of the vascular lesion. He survived a complicated early period after renal transplantation and has shown no recurrence of microangiopathic hemolytic anemia in the 18 months since transplantation. Special red blood cell and fibrinogen studies are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1094830     DOI: 10.1016/0002-9343(75)90643-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  De novo hemolytic uremic syndrome following renal transplantation.

Authors:  B M Chavers; T G Wells; B A Burke; S M Mauer
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

2.  Post-transplantation outcome of patients with hemolytic-uremic syndrome: update.

Authors:  D Hébert; E M Kim; R K Sibley; M S Mauer
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

3.  Recurrent haemolytic uraemic syndrome in a transplant recipient on orthoclone (OKT 3).

Authors:  D J Goodman; R G Walker; I E Birchall; A J d'Apice; H R Powell; P Kincaid-Smith
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.